drugset

drugset / Trial / NCT01709136

Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

NCT01709136 ↗

Phase 2/3 Terminated 3 enrolled University of Pittsburgh

NaSingle-groupOpen-labelTreatment

Summary

Pharmacokinetics of Tacrolimus and Sirolimus alone and in combination in liver transplant recipients.

Timeline

Start: 2005-12
Primary completion: 2010-01
Completion: 2010-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sirolimus	Small molecule	2 mg/m2	—

Indications